Global and United States Cancer Biotherapy Market Report & Forecast 2023-2028

Report ID: 1830715 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cancer Biotherapy Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cancer Biotherapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cancer Biotherapy Market Size for the Year 2017-2028
        1.2.2 Global Cancer Biotherapy Market Size for the Year 2017-2028
    1.3 Cancer Biotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cancer Biotherapy in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cancer Biotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cancer Biotherapy Market Dynamics
        1.4.1 Cancer Biotherapy Industry Trends
        1.4.2 Cancer Biotherapy Market Drivers
        1.4.3 Cancer Biotherapy Market Challenges
        1.4.4 Cancer Biotherapy Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cancer Biotherapy by Type
    2.1 Cancer Biotherapy Market Segment by Type
        2.1.1 Monoclonal Antibodies
        2.1.2 Vaccines
        2.1.3 Erythropoietin
        2.1.4 Colony Stimulating Factors
        2.1.5 Interleukins and Interferons
    2.2 Global Cancer Biotherapy Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cancer Biotherapy Market Size by Type (2017-2028)
    2.4 United States Cancer Biotherapy Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cancer Biotherapy Market Size by Type (2017-2028)
3 Cancer Biotherapy by Application
    3.1 Cancer Biotherapy Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Diagnostic Laboratories
        3.1.3 Research and Academic Laboratories
        3.1.4 Pharmaceutical and Biotechnology Companies
        3.1.5 Others
    3.2 Global Cancer Biotherapy Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cancer Biotherapy Market Size by Application (2017-2028)
    3.4 United States Cancer Biotherapy Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cancer Biotherapy Market Size by Application (2017-2028)
4 Global Cancer Biotherapy Competitor Landscape by Company
    4.1 Global Cancer Biotherapy Market Size by Company
        4.1.1 Top Global Cancer Biotherapy Companies Ranked by Revenue (2021)
        4.1.2 Global Cancer Biotherapy Revenue by Player (2017-2022)
    4.2 Global Cancer Biotherapy Concentration Ratio (CR)
        4.2.1 Cancer Biotherapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Biotherapy in 2021
        4.2.3 Global Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cancer Biotherapy Headquarters, Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cancer Biotherapy Headquarters and Area Served
        4.3.2 Global Cancer Biotherapy Companies Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cancer Biotherapy Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cancer Biotherapy Market Size by Company
        4.5.1 Top Cancer Biotherapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cancer Biotherapy Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Biotherapy Market Size by Region
    5.1 Global Cancer Biotherapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cancer Biotherapy Market Size by Region (2017-2028)
        5.2.1 Global Cancer Biotherapy Market Size by Region: 2017-2022
        5.2.2 Global Cancer Biotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cancer Biotherapy Market Size YoY Growth 2017-2028
        6.1.2 North America Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cancer Biotherapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cancer Biotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cancer Biotherapy Market Size YoY Growth 2017-2028
        6.3.2 Europe Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cancer Biotherapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cancer Biotherapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Company Details
        7.1.2 Amgen Business Overview
        7.1.3 Amgen Cancer Biotherapy Introduction
        7.1.4 Amgen Revenue in Cancer Biotherapy Business (2017-2022)
        7.1.5 Amgen Recent Development
    7.2 Bristol-Myers Squibb
        7.2.1 Bristol-Myers Squibb Company Details
        7.2.2 Bristol-Myers Squibb Business Overview
        7.2.3 Bristol-Myers Squibb Cancer Biotherapy Introduction
        7.2.4 Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2017-2022)
        7.2.5 Bristol-Myers Squibb Recent Development
    7.3 Celgene
        7.3.1 Celgene Company Details
        7.3.2 Celgene Business Overview
        7.3.3 Celgene Cancer Biotherapy Introduction
        7.3.4 Celgene Revenue in Cancer Biotherapy Business (2017-2022)
        7.3.5 Celgene Recent Development
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Company Details
        7.4.2 GlaxoSmithKline Business Overview
        7.4.3 GlaxoSmithKline Cancer Biotherapy Introduction
        7.4.4 GlaxoSmithKline Revenue in Cancer Biotherapy Business (2017-2022)
        7.4.5 GlaxoSmithKline Recent Development
    7.5 Eli Lilly
        7.5.1 Eli Lilly Company Details
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Cancer Biotherapy Introduction
        7.5.4 Eli Lilly Revenue in Cancer Biotherapy Business (2017-2022)
        7.5.5 Eli Lilly Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cancer Biotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cancer Biotherapy Market Trends
    Table 3. Cancer Biotherapy Market Drivers
    Table 4. Cancer Biotherapy Market Challenges
    Table 5. Cancer Biotherapy Market Restraints
    Table 6. Global Cancer Biotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Biotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Biotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Biotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Biotherapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Biotherapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cancer Biotherapy Revenue Share by Player, 2017-2022
    Table 13. Global Cancer Biotherapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cancer Biotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2021)
    Table 15. Top Players of Cancer Biotherapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cancer Biotherapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cancer Biotherapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cancer Biotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cancer Biotherapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cancer Biotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cancer Biotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cancer Biotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cancer Biotherapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Amgen Company Details
    Table 31. Amgen Business Overview
    Table 32. Amgen Cancer Biotherapy Product
    Table 33. Amgen Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 34. Amgen Recent Development
    Table 35. Bristol-Myers Squibb Company Details
    Table 36. Bristol-Myers Squibb Business Overview
    Table 37. Bristol-Myers Squibb Cancer Biotherapy Product
    Table 38. Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 39. Bristol-Myers Squibb Recent Development
    Table 40. Celgene Company Details
    Table 41. Celgene Business Overview
    Table 42. Celgene Cancer Biotherapy Product
    Table 43. Celgene Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 44. Celgene Recent Development
    Table 45. GlaxoSmithKline Company Details
    Table 46. GlaxoSmithKline Business Overview
    Table 47. GlaxoSmithKline Cancer Biotherapy Product
    Table 48. GlaxoSmithKline Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 49. GlaxoSmithKline Recent Development
    Table 50. Eli Lilly Company Details
    Table 51. Eli Lilly Business Overview
    Table 52. Eli Lilly Cancer Biotherapy Product
    Table 53. Eli Lilly Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 54. Eli Lilly Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Biotherapy Product Picture
    Figure 2. Global Cancer Biotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Biotherapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cancer Biotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cancer Biotherapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cancer Biotherapy Market Share in Global 2017-2028
    Figure 7. Cancer Biotherapy Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibodies
    Figure 9. Product Picture of Vaccines
    Figure 10. Product Picture of Erythropoietin
    Figure 11. Product Picture of Colony Stimulating Factors
    Figure 12. Product Picture of Interleukins and Interferons
    Figure 13. Global Cancer Biotherapy Market Share by Type in 2022 & 2028
    Figure 14. Global Cancer Biotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Cancer Biotherapy Market Share by Type (2017-2028)
    Figure 16. United States Cancer Biotherapy Market Share by Type in 2022 & 2028
    Figure 17. United States Cancer Biotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Cancer Biotherapy Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Diagnostic Laboratories
    Figure 21. Product Picture of Research and Academic Laboratories
    Figure 22. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 23. Product Picture of Others
    Figure 24. Global Cancer Biotherapy Market Share by Application in 2022 & 2028
    Figure 25. Global Cancer Biotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Cancer Biotherapy Market Share by Application (2017-2028)
    Figure 27. United States Cancer Biotherapy Market Share by Application in 2022 & 2028
    Figure 28. United States Cancer Biotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Cancer Biotherapy Market Share by Application (2017-2028)
    Figure 30. North America Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Amgen Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 60. Celgene Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 62. Eli Lilly Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Bristol-Myers Squibb
Celgene
GlaxoSmithKline
Eli Lilly
Frequently Asked Questions
Cancer Biotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Biotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Biotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports